Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis.

Rajavelu P, Rayapudi M, Moffitt M, Mishra A, Mishra A.

Am J Physiol Gastrointest Liver Physiol. 2012 Apr;302(7):G645-54. doi: 10.1152/ajpgi.00223.2011. Epub 2011 Dec 29.

2.

Allergen-induced interleukin-18 promotes experimental eosinophilic oesophagitis in mice.

Dutt P, Shukla JS, Ventateshaiah SU, Mariswamy SJ, Mattner J, Shukla A, Mishra A.

Immunol Cell Biol. 2015 Nov;93(10):849-57. doi: 10.1038/icb.2015.30. Epub 2015 Mar 24. Erratum in: Immunol Cell Biol. 2015 Nov;93(10):914.

3.

Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy.

Lexmond WS, Neves JF, Nurko S, Olszak T, Exley MA, Blumberg RS, Fiebiger E.

Am J Gastroenterol. 2014 May;109(5):646-57. doi: 10.1038/ajg.2014.12. Epub 2014 Feb 11.

4.

Pathogenic role of mast cells in experimental eosinophilic esophagitis.

Niranjan R, Mavi P, Rayapudi M, Dynda S, Mishra A.

Am J Physiol Gastrointest Liver Physiol. 2013 Jun 15;304(12):G1087-94. doi: 10.1152/ajpgi.00070.2013. Epub 2013 Apr 18.

5.

Pathogenesis of allergen-induced eosinophilic esophagitis is independent of interleukin (IL)-13.

Niranjan R, Rayapudi M, Mishra A, Dutt P, Dynda S, Mishra A.

Immunol Cell Biol. 2013 Jul;91(6):408-15. doi: 10.1038/icb.2013.21. Epub 2013 May 21.

6.

Involvement of interleukin-18 in the pathogenesis of human eosinophilic esophagitis.

Niranjan R, Rajavelu P, Ventateshaiah SU, Shukla JS, Zaidi A, Mariswamy SJ, Mattner J, Fortgang I, Kowalczyk M, Balart L, Shukla A, Mishra A.

Clin Immunol. 2015 Apr;157(2):103-13. doi: 10.1016/j.clim.2015.01.007. Epub 2015 Jan 28.

7.

Targeting AMCase reduces esophageal eosinophilic inflammation and remodeling in a mouse model of egg induced eosinophilic esophagitis.

Cho JY, Rosenthal P, Miller M, Pham A, Aceves S, Sakuda S, Broide DH.

Int Immunopharmacol. 2014 Jan;18(1):35-42. doi: 10.1016/j.intimp.2013.10.026. Epub 2013 Nov 13.

8.

Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet.

Spergel JM, Brown-Whitehorn TF, Cianferoni A, Shuker M, Wang ML, Verma R, Liacouras CA.

J Allergy Clin Immunol. 2012 Aug;130(2):461-7.e5. doi: 10.1016/j.jaci.2012.05.021. Epub 2012 Jun 27.

PMID:
22743304
9.

Eosinophilic esophagitis: an immune-mediated esophageal disease.

Weinbrand-Goichberg J, Segal I, Ovadia A, Levine A, Dalal I.

Immunol Res. 2013 Jul;56(2-3):249-60. doi: 10.1007/s12026-013-8394-y. Review.

PMID:
23579771
10.

TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis.

Collison AM, Sokulsky LA, Sherrill JD, Nightingale S, Hatchwell L, Talley NJ, Walker MM, Rothenberg ME, Mattes J.

J Allergy Clin Immunol. 2015 Oct;136(4):971-82. doi: 10.1016/j.jaci.2015.03.031. Epub 2015 May 13.

11.

Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.

Judd LM, Heine RG, Menheniott TR, Buzzelli J, O'Brien-Simpson N, Pavlic D, O'Connor L, Al Gazali K, Hamilton O, Scurr M, Collison AM, Mattes J, Allen KJ, Giraud AS.

Am J Physiol Gastrointest Liver Physiol. 2016 Jan 1;310(1):G13-25. doi: 10.1152/ajpgi.00290.2015. Epub 2015 Oct 29.

12.

Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE.

Clayton F, Fang JC, Gleich GJ, Lucendo AJ, Olalla JM, Vinson LA, Lowichik A, Chen X, Emerson L, Cox K, O'Gorman MA, Peterson KA.

Gastroenterology. 2014 Sep;147(3):602-9. doi: 10.1053/j.gastro.2014.05.036. Epub 2014 Jun 4.

PMID:
24907494
13.

TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis.

Sokulsky LA, Collison AM, Nightingale S, Fevre AL, Percival E, Starkey MR, Hansbro PM, Foster PS, Mattes J.

Am J Physiol Gastrointest Liver Physiol. 2016 Dec 1;311(6):G998-G1008. doi: 10.1152/ajpgi.00151.2016. Epub 2016 Oct 13.

PMID:
27742702
14.

Cellular and molecular immunological mechanisms in eosinophilic esophagitis: an updated overview of their clinical implications.

Lucendo AJ.

Expert Rev Gastroenterol Hepatol. 2014 Aug;8(6):669-85. doi: 10.1586/17474124.2014.909727. Epub 2014 Apr 18. Review.

PMID:
24742298
15.

Allergen-induced resistin-like molecule-α promotes esophageal epithelial cell hyperplasia in eosinophilic esophagitis.

Mavi P, Niranjan R, Dutt P, Zaidi A, Shukla JS, Korfhagen T, Mishra A.

Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1;307(5):G499-507. doi: 10.1152/ajpgi.00141.2014. Epub 2014 Jul 3. Erratum in: Am J Physiol Gastrointest Liver Physiol. 2015 Aug 15;309(4):G281.

16.

Immunohistochemical differentiation of eosinophilic esophageal myositis from eosinophilic esophagitis.

Sato H, Nakajima N, Hasegawa G, Kawata Y, Sato Y, Suzuki K, Honma T, Terai S.

J Gastroenterol Hepatol. 2017 Jan;32(1):106-113. doi: 10.1111/jgh.13466.

PMID:
27262491
17.

Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis.

Rayapudi M, Rajavelu P, Zhu X, Kaul A, Niranjan R, Dynda S, Mishra A, Mattner J, Zaidi A, Dutt P, Mishra A.

Clin Transl Immunology. 2014 Jan 10;3(1):e9. doi: 10.1038/cti.2013.13. eCollection 2014 Jan.

18.

The pathogenesis of chronic eosinophilic esophagitis in SHARPIN-deficient mice.

Chien SJ, Silva KA, Kennedy VE, HogenEsch H, Sundberg JP.

Exp Mol Pathol. 2015 Dec;99(3):460-7. doi: 10.1016/j.yexmp.2015.08.012. Epub 2015 Aug 29.

19.

Atopic and non-atopic eosinophilic oesophagitis are distinguished by immunoglobulin E-bearing intraepithelial mast cells.

Mulder DJ, Mak N, Hurlbut DJ, Justinich CJ.

Histopathology. 2012 Nov;61(5):810-22. doi: 10.1111/j.1365-2559.2012.4303.x. Epub 2012 Sep 17.

PMID:
22978418
20.

Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet.

Kagalwalla AF, Shah A, Li BU, Sentongo TA, Ritz S, Manuel-Rubio M, Jacques K, Wang D, Melin-Aldana H, Nelson SP.

J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):145-9. doi: 10.1097/MPG.0b013e31821cf503.

PMID:
21788754

Supplemental Content

Support Center